logo
‘It's deadly': The risks of drowning and knowing how to save a life

‘It's deadly': The risks of drowning and knowing how to save a life

Yahooa day ago

AUSTIN (KXAN) — Local first responders would like people to know what to do in case of a drowning.
Austin Public Health said an average of 14 people a year die by drowning in Travis County. Between 2007 and 2016, a total of 140 deaths happened due to unintentional drowning. Half of them were in natural bodies of water — like creeks, lakes or rivers — while 25% of them were in swimming pools.
It's why first responders are highlighting the life-saving power of CPR and of an automated external defibrillator, or AED.
Captain Trevor Stokes with Travis County Emergency Services District No. 2, otherwise known as the Pflugerville Fire Department, joined KXAN's Will DuPree and Avery Travis to mark CPR and AED Awareness Week.Avery Travis: We know this week is really meant to highlight how people can save lives and be safe out on the water. But let's talk about the issue of drowning. How big of a problem is it in Central Texas? I think a lot of folks growing up in this area learned to swim growing up, or were around swimming pools or the lake. Why might that knowledge maybe make us a little lax about the risks of drowning.
Captain Trevor Stokes: So the biggest issue we see is obviously for children, so we recommend putting all the efforts into prevention. Obviously, knowing CPR is a good thing, but at that point, something's already happened. So drowning is silent. It's deadly, and it happens very quickly. So when enjoying water, especially in pools or even an open body of water, like we saw with the incident there at Lake Austin or Town Lake, is having a PFD, wearing a PFD, not just having it near you, but actually wearing it despite your ability to swim. That's a preventative measure. People typically don't drown when they're wearing a PFD. They surface to the top of the water. But more importantly, with kiddos, always having somebody who is watching the children, and then rotating that person regularly. So that's not someone who's reading a book, who's on their phone, they're not distracted, they're watching. Also, if you're in a pool, or if you're in a body of water where visibility is good, having a swimsuit that is not the same color as, say, the bottom of the pool. So that at any moment a kid slips below the surface, you immediately can recognize that. But rotating that person and making sure they understand what their responsibilities are prevents it. Also having likes or any prevention mechanisms so people can't wander off to the water, wander off to the pool, unaided or unassisted or even unwatched, that's a big thing.
Will DuPree: Okay, so those are lots of things that people can keep in mind for sure. But if an emergency should happen, obviously calling 911, is important, but so is the importance of someone being a bystander who can jump in and perform CPR. What's the impact that can have on potentially saving someone's life?
Stokes: So having knowledge of doing CPR and immediately starting that process while someone is calling 911 — it raises the potential for a save so much higher. CPR is an easy skill to learn. Anyone can do it. You can go to pflugervillefire.org. Actually, the Pflugerville Firefighters Association has a free class that goes on monthly. All the information is on our website. There's also a playlist that will help you remember the tempo. But early compressions, early CPR is the best chance to make that a survivable event.
Travis: I think we even have that playlist pulled up so we can give it a scroll and let people see some of the songs you guys are actually trying to make this, you know, even entertaining and catchy, something easy for people to remember and learn and kind of put those skills into practice. I saw a Sabrina Carpenter song on there, and so I'll be practicing my CPR to that later today. So we're showing that resource for people and where you can find it. But I do want to ask for someone who the thought of jumping in as a bystander might be really scary, even if they've practiced, even if they've learned the skills. What would you say to folks, who you know that's a scary moment, to jump in and try to do something like that, if you've only ever practiced, maybe on a practice dummy or in a class?
Stokes: Well, it's interesting. We're doing Stillwater training right now at Lake Pflugerville. Last year, while we were out there doing that, someone actually started drowning while we were there. So as first responders, we're trained to do that. But even that group had a little hesitation, because they're like, surely, this is not happening right in front of us. So even for trained professionals, it can be stressful. The reality, though, is paying attention, making sure that someone is always watching, especially with kiddos, we can prevent that from ever happening.
DuPree: We mentioned a little bit earlier about the device known as an AED, talk to us about what that is and how helpful it can be in an emergency.
Stokes: So an AED is an automated external defibrillator, so it's a piece of equipment that has become very popular in public places all across the world. You'll see them in malls. You'll see them in airports. The way they're designed now is you don't need any training in them. As a matter of fact, some of the manufacturers prefer you don't have some training on, say, another brand, and then have to use that from the time you turn it on, it will walk you through every single step. Those that are located near a pool or a body of water — there's very specific directions drawing the person off before you do it. But other than that, it allows the best chance to restart the heart, should it be an electrical issue.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

Associated Press

time2 hours ago

  • Associated Press

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 data support vepdegestrant as a potential treatment option in patients with ESR1m ER+/HER2- advanced or metastatic breast cancer – NEW HAVEN, Conn., June 06, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) with its partner Pfizer Inc. (NYSE: PFE), for vepdegestrant for the treatment of patients with ER-positive (ER+)/human epidermal growth factor receptor 2 (HER2)-negative (ER+/HER2-) ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. This submission is based on results from VERITAC-2 (NCT05654623), a global, randomized Phase 3 trial evaluating vepdegestrant versus fulvestrant. 'This milestone comes after an exciting presentation at the American Society of Clinical Oncology's annual meeting,' said John Houston, Ph.D., Chairperson, Chief Executive Officer and President at Arvinas. 'We look forward to the NDA review and to the first ever FDA-approved PROTAC ER degrader potentially being available to patients who could benefit from a much needed, new treatment option.' Vepdegestrant is being jointly developed by Arvinas and Pfizer for the treatment of patients with advanced or metastatic ER+/HER2- breast cancer and was granted fast track designation as a monotherapy by the FDA. Results from the VERITAC-2 study were recently presented in a late-breaking oral presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting and were selected for the ASCO press briefing and for Best of ASCO. Detailed results were also simultaneously published in the New England Journal of Medicine. About the VERITAC-2 Clinical Trial The Phase 3 VERITAC-2 clinical trial ( NCT05654623 ) is a global, randomized trial evaluating the efficacy and safety of vepdegestrant (ARV-471) as a monotherapy compared to fulvestrant in patients with ER+/HER2- advanced or metastatic breast cancer. The trial enrolled 624 patients at sites in 25 countries who had previously received treatment with a CDK4/6 inhibitor plus endocrine therapy. Patients were randomized 1:1 to receive either vepdegestrant once daily, orally on a 28-day continuous dosing schedule, or fulvestrant, administered intramuscularly on Days 1 and 15 of Cycle 1 and then on Day 1 of each 28-day cycle starting from Day 1 of Cycle 2. In the trial, 43% of patients (n=270) had ESR1 mutations detected. The primary endpoint was progression-free survival (PFS) in the ESR1-mutation and intent-to-treat populations as determined by blinded independent central review. Overall survival is the key secondary endpoint. About Vepdegestrant Vepdegestrant is an investigational, orally bioavailable PROTAC (PROteolysis TArgeting Chimera) protein degrader designed to specifically target and degrade the estrogen receptor (ER). Vepdegestrant is being developed as a potential monotherapy for ER+/HER2- advanced or metastatic breast cancer with estrogen receptor 1 (ESR1) mutations in the second line-plus setting. In July 2021, Arvinas announced a global collaboration with Pfizer for the co-development and co-commercialization of vepdegestrant; Arvinas and Pfizer will share worldwide development costs, commercialization expenses, and profits. The U.S. Food and Drug Administration (FDA) has granted vepdegestrant Fast Track designation as a monotherapy in the treatment of adults with ER+/HER2- advanced or metastatic breast cancer previously treated with endocrine-based therapy. About Arvinas Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform, the Company is pioneering the development of protein degradation therapies designed to harness the body's natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; and ARV-102, targeting LRRK2 for neurodegenerative disorders. Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit and connect on LinkedIn and X. Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding: the NDA review and to the first ever FDA-approved PROTAC ER degrader potentially being available to patients who could benefit from a much needed, new treatment option; and vepdegestrant's development as a potential monotherapy for ER+/HER2- advanced or metastatic breast cancer with ESR1 mutations in the second line-plus setting. All statements, other than statements of historical fact, contained in this press release, including statements regarding Arvinas' strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words 'anticipate,' 'believe,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'target,' 'goal,' 'potential,' 'will,' 'would,' 'could,' 'should,' 'look forward,' 'continue,' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Arvinas may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements, and you should not place undue reliance on such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements Arvinas makes as a result of various risks and uncertainties, including but not limited to: whether Arvinas and Pfizer will successfully perform their respective obligations under the collaboration between Arvinas and Pfizer; whether Arvinas and Pfizer will be able to successfully conduct and complete clinical development for vepdegestrant as a monotherapy; whether the VERITAC-2 clinical trial will meet the secondary endpoint for overall survival; risks related to our expectations regarding the potential clinical benefit of vepdegestrant to patients; uncertainties relating to regulatory applications and related filing and approval timelines, including the New Drug Application seeking FDA approval of vepdegestrant and the risk that any regulatory approvals, if granted, may be subject to significant limitations on use or subject to withdrawal or other adverse actions by the applicable regulatory authority; whether FDA or other regulatory authorities will require additional information or further studies, or may fail or refuse to approve or may delay approval of vepdegestrant; whether Arvinas and Pfizer, as appropriate, will be able to obtain marketing approval for and commercialize vepdegestrant and other product candidates on current timelines or at all; Arvinas' ability to protect its intellectual property portfolio; Arvinas' reliance on third parties; whether Arvinas will be able to raise capital when needed; whether Arvinas' cash and cash equivalent resources will be sufficient to fund its foreseeable and unforeseeable operating expenses and capital expenditure requirements; and other important factors discussed in the 'Risk Factors' section of Arvinas' Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent other reports on file with the U.S. Securities and Exchange Commission. The forward-looking statements contained in this press release reflect Arvinas' current views with respect to future events, and Arvinas assumes no obligation to update any forward-looking statements, except as required by applicable law. These forward-looking statements should not be relied upon as representing Arvinas' views as of any date subsequent to the date of this release. Contacts Investors: Jeff Boyle +1 (347) 247-5089 [email protected] Media: Kirsten Owens +1 (203) 584-0307 [email protected]

How many drowning deaths happen per year in Travis County? What prevention resources are there?
How many drowning deaths happen per year in Travis County? What prevention resources are there?

Yahoo

time12 hours ago

  • Yahoo

How many drowning deaths happen per year in Travis County? What prevention resources are there?

AUSTIN (KXAN) — The Austin area has several bodies of water that people use for recreational activities like kayaking and swimming, which see an uptick in the warmer months. But with an increase in outdoor activity comes an increase in tragedies caused by accidents. Earlier this week, a teenage boy's body was recovered from Lady Bird Lake after investigators said he was 'unknowingly standing near an underwater shelf' when he slipped and did not resurface. Last week, another young boy died following an eighth grade graduation celebration at Dick Nichols Park. 'It's deadly': The risks of drowning and knowing how to save a life Drowning is the leading cause of death for children ages 1-4, and it's the second leading cause of accidental injury for children ages 5-14, according to the Centers for Disease Control and Prevention. KXAN looked at the number of accidental deaths caused by drowning, as reported by the Travis County Medical Examiner's annual reports over the last 10 years. By the numbers, Travis County saw the lowest number of drownings last year, compared to the other years within the last decade. According to the reports, the following number of accidental death drownings happened during the following years: 2024: 17 2023: 22 2022: 28 2021: 34 2020: 19 2019: 27 2018: 21 2017: 24 2016: 23 2015: 20 2014: 19 The Texas Department of Family and Protective Services also tracks child drowning deaths throughout the state. According to that agency, 22 children drowned in Texas so far this year. There are several water safety training programs in the Austin area. The city of Austin has an injury prevention page and a water safety page on its website. The city provides training and certifications for city-hired lifeguards. MAP: Tracking deaths in Lady Bird Lake in downtown Austin Aquatic Management of Austin also offers lifeguard training through two different courses -Lifeguarding, Full Certification (for new lifeguards), and Lifeguarding Recertification, for those who need to renew their current certification. Greater Austin YMCA, in collaboration with Colin's Hope, works to provide children with safety, aquatics, and fitness education. It's called Project SAFE, which stands for Safety, Aquatics and Fitness Education. The American Red Cross has several water safety certification programs and safety tips online. Goldfish Swim School has several indoor children's swim lessons and programs for children ages 4 months and up, and it offers safe swimming presentations to children in participating daycare centers, schools, and other educational facilities at no cost. UT Recreational Sports also has lifeguard certification classes for enrolled UT students. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Texas paramedics to get tuition exemptions already provided to firefighters, police thanks to passed bill
Texas paramedics to get tuition exemptions already provided to firefighters, police thanks to passed bill

Yahoo

time14 hours ago

  • Yahoo

Texas paramedics to get tuition exemptions already provided to firefighters, police thanks to passed bill

AUSTIN (KXAN) — Paramedics could soon be exempt from tuition and laboratory fees while taking certain courses at public colleges and universities, thanks to a bill that recently passed in the Texas Legislature. House Bill 1105, authored by Rep. Sheryl Cole, D-Austin, applies to paramedics employed by a political subdivision of Texas. Many of Texas' paramedics are also firefighters, who already have access to fee exemptions under Texas law. Law enforcement officers also have access to exemptions. However, an author-sponsor statement of intent for HB 1105 states that as many as 6,000 paramedics in Texas are not employed by a fire department. 'In Texas, most paramedics working for a political subdivision are also employed as firefighters,' the statement reads. 'Since firefighters are eligible … most paramedics have likewise benefited from these courses and the tuition exemption.' When implemented, the law will direct the Texas Higher Education Coordinating Board to restrict how many remote students get exemptions to 20% of enrolled students. Austin EMS Association (AEMSA) President James Monks provided the only testimony in support of the bill during an April 15 hearing, according to legislative records. AEMSA organizes Austin-Travis County EMS workers. 'I think it was an oversight. EMS is not quite at the top of everybody's radar,' said Monks to KXAN on Thursday. 'We got left out of the loop when [fee exemption] legislation initially passed, and I just tried to convince them that the initial intent of this legislation was to include paramedics … third service just kind of got left out.' Representatives from the city of Austin, city of Houston, Texas AFL-CIO, Texas State Association of Fire and Emergency Districts, Texas Fire Chiefs Association, Conference of Urban Counties, and County Judges and Commissioners Association of Texas registered in support of the bill but did not testify. No one testified against or registered opposition with the Senate's Higher Education committee. Texas AFL-CIO: Texas Legislature passes bill protecting utility workers from assaults, harassment during disasters Some AEMSA members have already indicated they will seek more training because of the bill, Monks said. He also said that the law would help ATCEMS retain staff. 'I definitely see it as step in the right direction,' Monks said. 'It's offering a further incentive for people who have their paramedic license or certification, so that they can go ahead and pursue higher education.' Bill sponsor Sen. Sarah Eckhardt, D-Austin, provided a statement to KXAN, in which she said she was proud to help pass the bill. 'Nearly 9% of Texas paramedics are employed by a standalone EMS department but are excluded from participating in the tuition exemption program offered to their counterparts who work jointly with police and fire,' Eckhardt said. 'This bill is about ensuring parity and opening vital pathways for more Texans to get to work helping their communities, especially those struggling with the greatest need for personnel.' Monks also told KXAN that he was grateful for Cole and Eckhardt, and said that their staff were 'fantastic.' Unless vetoed, HB 1105 takes effect in September. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store